Aimei Health Technology Co., Ltd. (AFJK): Nasdaq/NYSE listing notice — Aimei Health receives Nasdaq delisting notice for late 10-K filing

Aimei Health Technology Co., Ltd.

Nasdaq notified Aimei on April 17, 2026 of non-compliance with Listing Rule 5250(c)(1) due to overdue Annual Report for FY2025.
Annual Report was due March 31, 2026; company filed a 12b-25 extension on April 1, 2026.
Company has 60 calendar days to file the 10-K or submit a compliance plan; potential grace period up to 180 days from due date.
No immediate effect on trading, but failure to regain compliance may lead to delisting of AFJK securities.
Aimei is a blank-check SPAC; late filing raises execution risk for its planned business combination.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Aimei Health Technology Co., Ltd. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

April 17, 2026, Aimei Health Technology Co., Ltd (the “ Company ”) received a notice (the “ Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that because the Company had not yet filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “ Annual Report ”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) requiring Nasdaq-listed companies to timely file all periodic financial reports with the U.S. Securities and Exchange Commission (the “ SEC

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Aimei Health Technology Co., Ltd. filing history →

Source: SEC EDGAR

accession 0001493152-26-018216

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.